Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C46H58N4O9.H2O4S |
Molecular Weight | 909.053 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O.[H][C@@]12N3CC[C@@]14C5=CC(=C(OC)C=C5N(C)[C@@]4([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]6(C[C@H]7CN(C[C@](O)(CC)C7)CCC8=C6NC9=C8C=CC=C9)C(=O)OC
InChI
InChIKey=KDQAABAKXDWYSZ-PNYVAJAMSA-N
InChI=1S/C46H58N4O9.H2O4S/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7;1-5(2,3)4/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3;(H2,1,2,3,4)/t28-,37-,38+,39+,42-,43+,44+,45-,46-;/m0./s1
Molecular Formula | C46H58N4O9 |
Molecular Weight | 810.9741 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 9 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | H2O4S |
Molecular Weight | 98.078 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:59:50 UTC 2023
by
admin
on
Fri Dec 15 14:59:50 UTC 2023
|
Record UNII |
N00W22YO2B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C67422
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
||
|
FDA ORPHAN DRUG |
867921
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
||
|
NCI_THESAURUS |
C932
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
VINBLASTINE SULFATE
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | Description: A white to slightly yellow, amorphous or crystalline powder. Solubility: Freely soluble in water; very slightly soluble in ethanol (~750 g/l) TS; practically insoluble in ether R. Category: Cytotoxic drug. Storage: Vinblastine sulfate should be kept in a tightly closed container, protected from light, and stored at a temperature between 2 and 8 ?C. Additional information: CAUTION: Vinblastine sulfate must be handled with care, avoiding contact with the skin and inhalation of airborne particles. It is very hygroscopic and unstable. Before the bottle is opened, it should be allowed to come to room temperature in a desiccator. Requirement: Vinblastine sulfate contains not less than 96.0% and not more than the equivalent of 101.0% of C46H58N4O9,H2SO4, calculated with reference to the dried substance. | ||
|
C931
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | |||
|
1713004
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | |||
|
100000087899
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | |||
|
N00W22YO2B
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | |||
|
11199
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | RxNorm | ||
|
m11449
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID601017133
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | |||
|
49842
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | |||
|
SUB05098MIG
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | |||
|
N00W22YO2B
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | |||
|
205-606-0
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | |||
|
DBSALT000644
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | |||
|
143-67-9
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | |||
|
9984
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | |||
|
5388983
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY | |||
|
CHEMBL159
Created by
admin on Fri Dec 15 14:59:50 UTC 2023 , Edited by admin on Fri Dec 15 14:59:50 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |